[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Lopinavir and Ritonavir Market Size study (Impact of COVID 19 on Market Share), by Type (Tablet, Capsule, Oral solution), by Application (Adults, Children 14 days of age and older) and Regional Forecasts 2020-2026

May 2020 | 200 pages | ID: GF2918C0271BEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Lopinavir and Ritonavir Market is valued approximately at USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Lopinavir and ritonavir are antiviral drugs used in combination to treat human immunodeficiency virus (HIV). This combination of drug is used with other HIV medications to help control HIV disease. It facilitates to reduce the amount of HIV in the patient body so as immune system can work well. This drug decreases the chance of catching HIV complications (such as new infections, cancer) and enhances quality of life. The combination of this drug belongs to a class of drugs known as HIV protease inhibitors. Increasing cases of HIV patients is one of the prominent factors contributing towards the market growth. For instance, the U.S. Department of Health & Human Services has estimated that about 37.9 million people living with HIV in 2018 globally, an increase 8 million since 2010. Furthermore, the outbreak of COVID-19 and ongoing clinical trails to test the efficacy of lopinavir and ritonavir in COVID-19 treatment is likely to create significant growth opportunity in the market over the forecast period. For instance, on April 2020, researchers at the Jin Yin-Tan Hospital China, found that the combination of lopinavir-ritonavir HIV antivirals led to rapid symptom improvement in COVID-19 patients. However, unwanted health effects impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Lopinavir and Ritonavir market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to increasing government funding along with high incidences of HIV infection in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as improving healthcare infrastructure, HIV epidemic would create lucrative growth prospects for the Lopinavir and Ritonavir market across Asia-Pacific region.

Major market player included in this report are:
AbbVie Inc.
Lannett Co Inc.

Hikma Pharmaceuticals
Cipla Limited
Mylan N.V.
Hetero Drugs
Aurobindo Pharma Ltd.
Amneal Pharmaceuticals Inc.
Rewine Pharmaceutical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Tablet
Capsule
Oral solution
By Application:
Adults
Children 14 days of age and older

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Lopinavir and Ritonavir Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

CHAPTER 1.EXECUTIVE SUMMARY

1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
  1.2.1.Lopinavir and Ritonavir Market, by Region, 2018-2026 (USD Billion)
  1.2.2.Lopinavir and Ritonavir Market, by Type, 2018-2026 (USD Billion)
  1.2.3.Lopinavir and Ritonavir Market, by Application, 2018-2026 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption

CHAPTER 2.GLOBAL LOPINAVIR AND RITONAVIR MARKET DEFINITION AND SCOPE

2.1.Objective of the Study
2.2.Market Definition & Scope
  2.2.1.Scope of the Study
  2.2.2.Industry Evolution
2.3.Years Considered for the Study
2.4.Currency Conversion Rates

CHAPTER 3.GLOBAL LOPINAVIR AND RITONAVIR MARKET DYNAMICS

3.1.Lopinavir and Ritonavir Market Impact Analysis (2018-2026)
  3.1.1.Market Drivers
  3.1.2.Market Challenges
  3.1.3.Market Opportunities

CHAPTER 4.GLOBAL LOPINAVIR AND RITONAVIR MARKET: INDUSTRY ANALYSIS

4.1.Porter’s 5 Force Model
  4.1.1.Bargaining Power of Suppliers
  4.1.2.Bargaining Power of Buyers
  4.1.3.Threat of New Entrants
  4.1.4.Threat of Substitutes
  4.1.5.Competitive Rivalry
  4.1.6.Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.PEST Analysis
  4.2.1.Political
  4.2.2.Economical
  4.2.3.Social
  4.2.4.Technological
4.3.Investment Adoption Model
4.4.Analyst Recommendation & Conclusion

CHAPTER 5.GLOBAL LOPINAVIR AND RITONAVIR MARKET, BY TYPE

5.1.Market Snapshot
5.2.Global Lopinavir and Ritonavir Market by Type, Performance - Potential Analysis
5.3.Global Lopinavir and Ritonavir Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4.Lopinavir and Ritonavir Market, Sub Segment Analysis
  5.4.1. Tablet
  5.4.2.Capsule
  5.4.3.Oral solution

CHAPTER 6.GLOBAL LOPINAVIR AND RITONAVIR MARKET, BY APPLICATION

6.1.Market Snapshot
6.2.Global Lopinavir and Ritonavir Market by Application, Performance - Potential Analysis
6.3.Global Lopinavir and Ritonavir Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4.Lopinavir and Ritonavir Market, Sub Segment Analysis
  6.4.1. Adults
  6.4.2.Children 14 days of age and older

CHAPTER 7.GLOBAL LOPINAVIR AND RITONAVIR MARKET, REGIONAL ANALYSIS

7.1.Lopinavir and Ritonavir Market, Regional Market Snapshot
7.2.North America Lopinavir and Ritonavir Market
  7.2.1.U.S. Lopinavir and Ritonavir Market
    7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
    7.2.1.2. Application breakdown estimates & forecasts, 2016-2026
  7.2.2.Canada Lopinavir and Ritonavir Market
7.3.Europe Lopinavir and Ritonavir Market Snapshot
  7.3.1.U.K. Lopinavir and Ritonavir Market
  7.3.2.Germany Lopinavir and Ritonavir Market
  7.3.3.Rest of Europe Lopinavir and Ritonavir Market
7.4.Asia-Pacific Lopinavir and Ritonavir Market Snapshot
  7.4.1.China Lopinavir and Ritonavir Market
  7.4.2.India Lopinavir and Ritonavir Market
  7.4.3.Japan Lopinavir and Ritonavir Market
  7.4.4.Rest of Asia Pacific Lopinavir and Ritonavir Market
7.5.Latin America Lopinavir and Ritonavir Market Snapshot
  7.5.1.Brazil Lopinavir and Ritonavir Market
  7.5.2.Mexico Lopinavir and Ritonavir Market
7.6.Rest of The World Lopinavir and Ritonavir Market

CHAPTER 8.COMPETITIVE INTELLIGENCE

8.1.Top Market Strategies
8.2.Company Profiles
  8.2.1. AbbVie Inc.
    8.2.1.1.Key Information
    8.2.1.2.Overview
    8.2.1.3.Financial (Subject to Data Availability)
    8.2.1.4.Product Summary
    8.2.1.5.Recent Developments
  8.2.2. Lannett Co Inc.
  8.2.3.
  8.2.4.Hikma Pharmaceuticals
  8.2.5.Cipla Limited
  8.2.6.Mylan N.V.
  8.2.7.Hetero DrugsETERO
  8.2.8.Aurobindo Pharma Ltd.
  8.2.9.Amneal Pharmaceuticals Inc.
  8.2.10.Rewine Pharmaceutical

CHAPTER 9.RESEARCH PROCESS

9.1.Research Process
  9.1.1.Data Mining
  9.1.2.Analysis
  9.1.3.Market Estimation
  9.1.4.Validation
  9.1.5.Publishing
9.2.Research Attributes
9.3.Research Assumption

LIST OF TABLES

TABLE 1.List of secondary sources, used in the study of global Lopinavir and Ritonavir market
TABLE 2.List of primary sources, used in the study of global Lopinavir and Ritonavir market
TABLE 3.Global Lopinavir and Ritonavir market, report scope
TABLE 4.Years considered for the study
TABLE 5.Exchange rates considered
TABLE 6.Global Lopinavir and Ritonavir market estimates & forecasts by region 2016-2026 (USD Billion)
TABLE 7.Global Lopinavir and Ritonavir market estimates & forecasts by Type 2016-2026 (USD Billion)
TABLE 8.Global Lopinavir and Ritonavir market estimates & forecasts by Application 2016-2026 (USD Billion)
TABLE 9.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 10.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 11.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 12.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 13.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 14.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 15.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 16.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 17.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 18.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD BILLION)
TABLE 19.U.S. Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD BILLION)
TABLE 20.U.S. Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
TABLE 21.U.S. Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
TABLE 22.CANADA Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD BILLION)
TABLE 23.CANADA Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
TABLE 24.Canada Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
TABLE 25.UK Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD BILLION)
TABLE 26.UK Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
TABLE 27.UK Lopinavir and Ritonavir Market Estimates & Forecasts by Segment 2016-2026 (USD BILLION)
TABLE 28.Germany Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 29.Germany Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 30.Germany Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 31.Roe Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 32.Roe Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 33.Roe Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 34.China Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 35.China Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 36.China Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 37.India Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 38.India Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 39.India Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 40.Japan Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 41.Japan Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 42.Japan Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 43.ROAPAC Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 44.ROAPAC Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 45.ROAPAC Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 46.Brazil Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 47.Brazil Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 48.Brazil Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 49.Mexico Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 50.Mexico Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 51.Mexico Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 52.ROLA Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 53.ROLA Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 54.ROLA Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 55.ROW Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 56.ROW Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 57.ROW Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)

LIST OF FIGURES

FIG 1.Global Lopinavir and Ritonavir market, research methodology
FIG 2.Global Lopinavir and Ritonavir market, market estimation techniques
FIG 3.Global market size estimates & forecast methods
FIG 4.Global Lopinavir and Ritonavir market, key trends 2019
FIG 5.Global Lopinavir and Ritonavir market, growth prospects 2020-2026
FIG 6.Global Lopinavir and Ritonavir market, porters 5 force model
FIG 7.Global Lopinavir and Ritonavir market, pest analysis
FIG 8.Global Lopinavir and Ritonavir market, value chain analysis
FIG 9.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
FIG 10.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
FIG 11.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
FIG 12.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
FIG 13.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
FIG 14.Global Lopinavir and Ritonavir market, regional snapshot 2016 & 2026
FIG 15.North America Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
FIG 16.Europe Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
FIG 17.Asia pacific Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
FIG 18.Latin America Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
FIG 19.Global Lopinavir and Ritonavir market, company market share analysis (2019)

COMPANIES MENTIONED

AbbVie Inc.
Lannett Co Inc.

Hikma Pharmaceuticals
Cipla Limited
Mylan N.V.
Hetero Drugs
Aurobindo Pharma Ltd.
Amneal Pharmaceuticals Inc.
Rewine Pharmaceutical


More Publications